TrsBiotech Revenue
Biotechnology Research • • 1-10 Employees
$
TrsBiotech revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at TrsBiotech
Ali Hashemi
Chief Executive Officer
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Employees | 1-10 |
About TrsBiotech
TrsBiotech vaccine development. With an emphasis on developing safe and effective vaccines. Developed a VLP recombinant vaccine for COVID-19 published by Frontier in Immunology. Currently in the research and development phase of the avian flu vaccine
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
TrsBiotech has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
TrsBiotech has never raised funding before.
France
United Kingdom
United States
Netherlands
Germany
PortugalFrequently asked questions
TrsBiotech is located in XX.
TrsBiotech generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
TrsBiotech has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
TrsBiotech has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
